Cynthia Smith Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

DRNA Quotes by TradingView

Cynthia Smith is Director of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 3,333 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $127,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Cynthia Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2021
SELL
Disposition due to a tender of shares in a change of control transaction
$127,487 $38.25 p/Share
3,333 Reduced 100.0%
0 Common Stock
Jun 03 2021
BUY
Exercise of conversion of derivative security
-
3,333 Added 50.0%
3,333 Common Stock

Also insider at

SPRO
Spero Therapeutics, Inc. Healthcare
TARA
Protara Therapeutics, Inc. Healthcare
AKBA
Akebia Therapeutics, Inc. Healthcare
AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
Director
CS

Cynthia Smith

Director
Cambridge, MA

Track Institutional and Insider Activities on DRNA

Follow Dicerna Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRNA shares.

Notify only if

Insider Trading

Get notified when an Dicerna Pharmaceuticals Inc insider buys or sells DRNA shares.

Notify only if

News

Receive news related to Dicerna Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DRNA